114P Nivolumab plus ipilimumab as first-line treatment for patients with advanced non-small cell lung cancer: A systematic review
2021 ◽
Vol 16
(4)
◽
pp. S759-S760
J. Tandiono
◽
S. Chen
◽
E. Marcella
◽
B. Susanto
◽
R.S. Heriyanto
◽
...
2019 ◽
Vol 20
(5)
◽
pp. 763-777
◽
Cuc Thi Thu Nguyen
◽
Fabio Petrelli
◽
Stefania Scuri
◽
Binh Thanh Nguyen
◽
Iolanda Grappasonni
2017 ◽
Vol 20
(9)
◽
pp. A438
TT Nguyen
◽
I Grappasonni
◽
TB Nguyen
◽
F Petrelli
2018 ◽
Vol 10
(12)
◽
pp. 6677-6694
◽
Lisa M. Hess
◽
Amy M. DeLozier
◽
Fanni Natanegara
◽
Xiaofei Wang
◽
Victoria Soldatenkova
◽
...
2013 ◽
Vol 16
(7)
◽
pp. A414-A415
I. Eijgelshoven
◽
S.C. Verduyn
◽
T. Bhatti
◽
C. Bexelius
◽
J.P. Jansen
2016 ◽
Vol 27
(suppl_9)
◽
Alessandro Di Federico
◽
Andrea De Giglio
◽
Claudia Parisi
◽
Francesco Gelsomino
◽
Luca Boni
◽
...
Y. Belaroussi
◽
S. Cousin
◽
M. Carton
◽
M. Lebitasy
◽
L. Laborde
◽
...
2020 ◽
Vol 9
(10)
◽
pp. 3328-3336
◽
Haiyan Xu
◽
Quan Zhang
◽
Li Liang
◽
Junling Li
◽
Zhefeng Liu
◽
...
2019 ◽
Vol 8
(8)
◽
pp. E11-E14
Teppei Yamaguchi
◽
Toyoaki Hida